Is this you? Create Your Porfile
Avatar

Y. Itoh

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Y. Itoh is active.

Explore More

Publication

Featured researches published by Y. Itoh.

European Urology Supplements | 2013

E80 Administration of the selective alpha 1A adrenoceptor antagonist silodosin facilitates expulsion of size 5–10 mm distal ureteral stones, as compared to control

Y. Itoh; A. Okada; K. Taguchi; Y. Hirose; K. Niimi; Y. Fujii; T. Kobayashi; M. Usami; S. Hamamoto; R. Ando; M. Hirose; T. Yasui; K. Tozawa; K. Kohri

Objective nRecently, we reported that alpha 1A-adrenoceptor (AR) is the main participant in phenylephrine-induced human ureteral contraction. We therefore decided to carry out a prospective randomized study to evaluate the effects of silodosin, a selective alpha 1A AR antagonist, as a medical expulsive therapy (MET) for distal ureteral stones.

European Urology Supplements | 2016

919 The role of M1/M2 macrophages for CaOx stone and Randall's plaque formation

K. Taguchi; A. Okada; S. Hamamoto; R. Unno; H. Kamisawa; T. Naiki; R. Ando; Y. Umemoto; Y. Itoh; K. Tozawa; K. Kohri; T. Yasui

European Urology Supplements | 2015

397 The roles of osteopontin in the kidney stone formation process as a stone matrix and activator of crystal-elimination by macrophages

A. Okada; K. Taguchi; S. Homamoto; M. Hirose; Y. Itoh; T. Yasui; K. Tozawa; K. Kohri

European Urology Supplements | 2014

803 M2 macrophages eliminate renal crystals by phagocytosis

K. Taguchi; A. Okada; T. Yasui; S. Iwatsuki; T. Hamakawa; Y. Hirose; S. Hamamoto; R. Ando; Y. Itoh; K. Tozawa; K. Kohri

European Urology Supplements | 2014

805 Three novel susceptibility loci identified from a genome-wide association study (GWAS) are associated with urolithiasis risk

T. Yasui; A. Okada; M. Usami; S. Hamamoto; R. Ando; Y. Itoh; S. Sasaki; Y. Hayashi; Y. Higashi; Y. Sato; K. Kohri

European Urology Supplements | 2014

804 PPAR-α/γ agonists have different effects on renal crystal formation in hyperoxaluric animal models

K. Taguchi; A. Okada; T. Yasui; S. Iwatsuki; T. Hamakawa; Y. Hirose; T. Kobayashi; S. Hamamoto; R. Ando; Y. Itoh; K. Tozawa; K. Kohri

European Urology Supplements | 2013

E18 Association of the loci 5q35.3, 7q14.3, and 13.q14.1 with urolithiasis in the Japanese population

T. Yasui; A. Okada; M. Usami; Y. Hirose; Y. Ito; K. Taguchi; Y. Fujii; K. Niimi; S. Hamamoto; R. Ando; M. Hirose; Y. Itoh; K. Tozawa; Y. Higashi; Y. Sato; K. Matsuda; K. Kohri

European Urology Supplements | 2013

E184 M2 macrophages phagocytose renal calcium oxalate crystals and suppress crystal formation in a colony-stimulating factor-1-dependent manner

K. Taguchi; A. Okada; T. Yasui; Y. Hirose; K. Niimi; S. Hamamoto; Y. Itoh; K. Tozawa; K. Kohri

European Urology Supplements | 2013

311 Active phagocytosis and processing of calcium oxalate monohydrate crystals in an in vitro macrophage model

A. Okada; T. Yasui; L. Zuo; K. Taguchi; Y. Fujii; Y. Itoh; Y. Hirose; M. Usami; K. Niimi; R. Ando; T. Kobayashi; S. Hamamoto; M. Hirose; K. Tozawa; K. Kohri

European Urology Supplements | 2013

E88 Macrophage-derived cytokines and chemokines may be novel markers to predict calcium oxalate stone formation in humans

A. Okada; T. Yasui; K. Taguchi; Y. Ito; Y. Hirose; Y. Fujii; K. Niimi; M. Usami; T. Kobayashi; S. Hamamoto; M. Hirose; Y. Itoh; K. Tozawa; K. Kohri

Explore More

Collaboration

Dive into the Y. Itoh's collaboration.

Explore More
Researchain Logo
Decentralizing Knowledge